ABSTRACT The scrapie agent causes a degenerative nervous system disorder of sheep and goats. Considerable evidence indicates that the scrapie agent contains a protein that is necessary for infectivity [Prusiner, S. B., Groth, D. F., Cochran, S. P., Masiarz, F. R., McKinley, M. P. & Martinez, H. M. (1980) Biochemistry 19, 4883-4891], but direct demonstration of a protein moiety has been hampered by lack ofsufficiently purified preparations. Employing preparations of the scrapie agent enriched 100-to 1000-fold with respect to protein, we found that digestion by proteinase K destroyed more than 99.9% of the infectivity. Diethylpyrocarbonate, which chemically modifies amino acid residues in proteins with high efficiency, also inactivated the scrapie agent in these purified preparations. Reductions of infectivity by proteinase K and diethylpyrocarbonate were not observed with less purified preparations. The agent bound to phenyl-Sepharose could not be eluted with 8.5 M ethylene glycol; however, a combination of ethylene glycol and detergents did release the agent. These observations provide good evidence for a protein and for hydrophobic domains within the scrapie agent. Whether the protein required for infectivity is the same protein responsible for the hydrophobic properties of the scrapie agent remains to be established.
The scrapie agent causes a degenerative nervous system disorder in sheep and goats and is considered a prototype for two similar disorders of humans: kuru and Creutzfeldt-Jakob disease (1) . Many months or even years pass from the time of exposure or inoculation until onset of neurological dysfunction; hence the term "slow virus" disease. Because the unusual properties of the scrapie agent readily distinguish it from conventional viruses, we prefer to use the term "unusual slow viruslike agent". Studies on the structure of unusual slow virus-like agents are of great interest because they may provide new approaches to the investigation of many common degenerative diseases of unknown etiology.
In this communication we show that the scrapie agent possesses a protein that is required for infectivity. The titer of the scrapie agent in a purified fraction was reduced by proteolytic digestion and by chemical modification. Hydrophobic chromatography provides further evidence for the hydrophobicity of the agent (2) .
Our findings that the scrapie agent contains a protein, to our knowledge, represent the most convincing identification so far of a macromolecule within the agent. The requirement. for a protein to maintain infectivity clearly separates the scrapie agent from infectious "naked" nucleic acids such as plant viroids (3) . To date we have been unable to identify a nucleic acid within the agent. These results raise the possibility that the genome coding for the scrapie agent protein may not reside within the infectious particle itself.
MATERIALS AND METHODS
Chemicals and Reagents. Crystalline proteinase K was purchased from Merck; micrococcal nuclease, phenylmethylsulfonyl fluoride (PhMeSO2F), and diethylpyrocarbonate (Et2PC) from Sigma; ribonucleases, and deoxyribonucleases from Worthington; phenyl-Sepharose from Pharmacia; and alkyl agaroses from Miles. Nonidet P40 (NP40), Triton X-100, Brij 35 , and sodium dodecyl sarcosinate (Sarkosyl) were obtained from Sigma. 1-Dodecylpropanediol-3-phosphocholine was purchased from Medmark (Munich, Federal Republic of Germany). Sulfiobetaine 3-14 (Zwittergent), sodium deoxycholate, and sodium cholate were purchased from Calbiochem. Enzyme grade (NH4)2S04 was obtained from Schwarz/Mann.
Source and Bioassay ofthe Scrapie Agent. Hamster-adapted scrapie agent was propagated and prepared as described (4) . The infectivity titer was determined by measuring the incubation time intervals from inoculation to onset of illness and to death; this procedure is a modification of the incubation period assay previously described (4) . Weanling female hamsters (LVG/ LAK) purchased from Charles River Breeding Laboratories were inoculated intracerebrally with 50 A1 ofsuspension at designated dilutions.
Partial Purification of Scrapie Agent. In a typical preparation, 200 weanling female hamsters (LVG/LAK) were inoculated intracerebrally with 107 ID50 (50% infective dose) units of hamster-adapted scrapie agent and were sacrificed 60-65 days later. All solutions were degassed under reduced pressure and purged with argon to remove oxygen. The brains were removed and immediately washed with ice-cold 320 mM sucrose. A 10% (wt/vol) homogenate in 320 mM sucrose was prepared using a Polytron device equipped with a PT35K generator. Homogenization was performed for 30 sec in a flask surrounded by ice water. The entire operation was carried out in a Baker Sterilgard biosafety hood. During homogenization the temperature cf the suspension was never allowed to exceed 150C. The titer of the homogenate varied between 107.5 and 108-5 ID50 units/ml and the protein concentration was 10 mg/ml. All subsequent operations were performed at 40C. The homogenate was centrifuged at 1000 rpm for 10 min in a Beckman JA-10 rotor. The supernatant fluid (S1) was decanted and centrifuged again at 2100.rpm for 30 min. To the supernatant fluid (S2), EDTA and dithiothreitol were added to give final concentrations of 5 mM each and the fluid was centrifuged in a Spinco Ti 15 zonal rotor at 32,000 rpm for 16 hr. The pellet (P3) was recovered on the external wall of the rotor by using a specially designed core that permitted removal of the supernatant fluid prior to opening the rotor. The (7) . The strategy for employing this procedure as well as conditions for Sarkosyl gel electrophoresis have been described (5) . The sample was then electrophoresed toward the anode through a short gel having a 2-cm path length. An electronic timing device provided automatic cycling of the electrophoresis system, which was operated at 100 mA (8) . After elution of a peak absorbing at 260 and 280 nm, the electrophoresis was terminated. The scrapie agent was removed by electroelution for 16 hr or by pulverizing the gel with a Brinkmann Polytron (9) . These fractions (designated E6) were eluted into 60 mM Tris-HOAc (pH 8.3)/1 mM EDTA/0.2% Sarkosyl. The titers of E6 fractions were 106.5 to 108.5 ID50 units/ml and the protein concentrations were 20-50 ug/ml. The degree of purification of the scrapie agent was generally 100-fold with respect to protein. In a few instances the degree of purification was as high as 1000-fold. The imprecision of the bioassay and a 100-5 to 101 ID 50units/ml reduction in titer upon sodium deoxycholate addition to fraction P3 undoubtedly contribute to this variability in degree of purification.
Phenyl-Sepharose Binding and Elution. Fraction P4 was digested with micrococcal nuclease and proteinase K and then diluted with an equal volume of buffer containing 100 mM Tris HCl (pH 7.8)/0.8 M KCV20% (vol/vol) glycerol/2 mM dithiothreitol/2% NP40/0.8% Sarkosyl (10) . Three milliliters of the diluted preparation was then bound to 1 ml of packed phenyl-Sepharose that had been equil--ibrated previously with this dilution buffer. Binding was allowed to proceed for 50 min at 40C with gentle mixing on a Vortex mixer at 5-min intervals. The phenyl-Sepharose was then separated from the diluent buffer by centrifugation at 40C for 10 min at 1800 rpm-in a Beckman J4.2 rotor. Subsequent washes of 6 ml each were performed twice and the supernatant fluids were combined.
RESULTS
In crude preparations, the scrapie agent is resistant to inactivation by a variety of hydrolytic enzymes, including proteases (Table 1) , (5, 11, 12) . In contrast, in fraction E6 proteinase K significantly reduced the titer ofthe scrapie agent. Ribonuclease A and deoxyribonuclease I did not inactivate the agent, but it should be noted that the presence of Sarkosyl reduced their catalytic activities. The resistance of the scrapie agent to inactivation by these nucleases diminishes the possibility that the inactivation observed with proteinase K was caused by a nonspecific contaminant. The extent ofinactivation by digestion with proteinase K at 100 ug/ml for 2-3 hr at 37C
varied between 101 and >103 IDso units/ml. Our data demonstrate that the extent of inactivation was dependent on enzyme concentration and duration ofdigestion (Fig. 1) . Digestion was optimal at 37TC, whereas at 600C it was ineffective even though proteinase K is active at this temperature (13) . Preliminary studies indicate that, in the presence of1 M KC1, digestion at 60TC with proteinase K reduced scrapie agent infectivity more than 104 ID50 units/ml (unpublished data). Other studies have shown that the scrapie agent is also inactivated by trypsin digestion (unpublished data).
To further probe the proteinaceous structure of the scrapie agent, the effect ofchemical modification ofamino acid residues on infectivity was determined. Addition of 10 mM Et2PC to fraction E6 led to a marked reduction in titer (Table 2) . Et2PC had no effect at 1 mM. Under the conditions of these experiments the half-life for Et2PC was =0.4 min, so that unreacted Et2PC was rapidly hydrolyzed (14) . In crude preparations, Et2PC (20, [22] [23] [24] . When Et2PC was added to preparations ofviral genomes, the double-stranded DNAs ofT4 and 3NT bacteriophage as well as the double-stranded RNA of the replicative form of poliovirus were unaltered as measured by transfection (20, 22) . In contrast, significant reductions in transfection were observed when the single-stranded RNA genomes of poliovirus, tobacco mosaic virus, and Q(3 bacteriophage were treated with Et2PC (21) (22) (23) (24) . Et2PC reacts with histidine residues 104 times more rapidly than with adenosine moieties of nucleic acids (14, 25) . Treatment of adenosine with Et2PC has been shown to result not only in opening of the imidazole ring but also in ethoxyformylation of the amino group. The studies with conventional viruses and their genomes are not directly comparable to our studies because the half-life of Et2PC is greatly influenced by the buffer composition and pH (14) . We are unaware of any published information concerning the NH2OH reversibility of Et2PC-inactivated conventional viruses or nucleic acids. Earlier studies providing evidence for a protein within the scrapie agent showed that it was inactivated by NaDodSO4, chaotropic ions, and phenol (4). Inactivation of the agent by NaDodSO4 occurred as the detergent-to-protein ratio approached 1.8 g of NaDodSO4 per g of protein (4) . At this ratio most proteins become completely denatured and their hydrophobic binding sites for NaDodSO4 are saturated (26) . Inactivation by NaDodSO4 could be prevented by addition of nonionic detergent (4). Chaotropic ions have also been found to be potent inactivators of the scrapie agent (4, 15, 27) . Exposure of the agent at 40C to 1 M guanidinium SCN reduced its titer >108 ID50 units/ml in less than 6 hr. Infectivity was not restored when guanidinium SCN was removed by dialysis (15) . Enzymatic activities of proteins are characteristically altered at concentrations ofchaotropic ions below 1 M (28, 29) . Changing the secondary structure ofnucleic acids requires chaotrope concentrations of4-5 M (30) . Several investigators have shown that the scrapie agent is readily inactivated by phenol (4, 31) . Interpretation of these results has varied, but denaturation ofa protein necessary for infectivity is a likely interpretation (4) . It is of interest that attempts to reconstitute infectious agent from both the aqueous and organic phases ofphenol-extracted preparations in liposome carriers have been unsuccessful to date (unpublished observations). In contrast to the denaturing organic solvent, phenol, ethanol precipitated the scrapie agent but did not inactivate it (4, 32) .
We do not know how many peptide bonds must be hydrolyzed or how many amino acid residues must be chemically modified for inactivation of the agent to occur. Nor do we have any information about the conformational state of the protein within the infectious agent that is most susceptible to protease degradation as well as chemical modification. Numerous studies in other systems have shown that the rate ofproteolysis depends upon the conformation of the protein substrate (33, 34) . Although Sarkosyl did not influence the titer of the scrapie agent in fraction E6 (4) , it may have shifted the agent into a conformational state that is susceptible to degradation by proteinase K. NaDodSO4, a structural analogue of Sarkosyl, has been shown to increase the rate ofproteinase K-catalyzed proteolysis (35) ; however, NaDodSO4 was not used in these studies because it inactivates the agent (4) . It (31) , papain at 590 tug/ml (32) , and Pronase at 2000 ,4g/ml (45) (46) . The endpoint titration datafor the Pronase sample was unusual because all of the mice inoculated with a 1:100 dilution of the sample died and all the mice inoculated with higher dilutions, with one exception, never developed scrapie (45) . Is it possible that these unusual titration data result from the vast amount of Pronase protein inhibiting the infectious process rather than enzymatically degrading the agent? Our studies with proteinase K control for this possibility because proteinase K added to fraction E6, followed immediately by PhMeSO2F addition and freezing, did not inactivate the agent (Fig. 1B) . It is of interest that the infectivity of tobacco mosaic virus was immediately diminished upon addition oftrypsin, chymotrypsin, or ribonuclease to the inocula (47 Although we now have abundant evidence that the scrapie agent contains a protein and that the protein is probably hydrophobic, we do not have evidence for a nucleic acid within the agent. The scrapie agent in purified preparations is resistant to psoralen crosslinking, Zn2+-catalyzed hydrolysis, and ultraviolet irradiation (unpublished data). Now that the presence of a protein has been demonstrated, an intensive search must be made for the genome ofthe agent (50, 51) . Does a genome coding for the scrapie agent protein reside within the infectious agent itselfor is the genome part ofthe cellular genetic material? Will the unusual properties of the scrapie agent, which distinguish it from conventional viruses, reveal unprecedented mechanisms of replication?
